NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,100,000 | +33.3% | 4,962,657 | +13.2% | 2.37% | -1.9% |
| Q3 2020 | $2,325,000 | -23.7% | 4,384,199 | -1.4% | 2.42% | -59.0% |
| Q2 2020 | $3,046,000 | -13.4% | 4,447,026 | -5.2% | 5.90% | +58.6% |
| Q1 2020 | $3,518,000 | -52.1% | 4,690,146 | -3.5% | 3.72% | -27.2% |
| Q4 2019 | $7,337,000 | +10.1% | 4,858,889 | +7.9% | 5.11% | -20.9% |
| Q3 2019 | $6,663,000 | +3.9% | 4,502,301 | -9.4% | 6.47% | +46.5% |
| Q2 2019 | $6,413,000 | -45.5% | 4,971,014 | +10.2% | 4.42% | -34.8% |
| Q1 2019 | $11,775,000 | +69.5% | 4,511,504 | +7.2% | 6.77% | +11.0% |
| Q4 2018 | $6,947,000 | +528.7% | 4,210,153 | +1747.2% | 6.10% | +844.4% |
| Q3 2018 | $1,105,000 | -22.6% | 227,919 | +62.8% | 0.65% | -24.5% |
| Q4 2017 | $1,428,000 | -65.4% | 140,000 | -75.2% | 0.86% | -61.6% |
| Q2 2017 | $4,125,000 | – | 565,100 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,971,014 | $6,413,000 | 4.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,711,454 | $4,788,000 | 0.66% |
| Proxima Capital Management, LLC | 206,000 | $266,000 | 0.36% |
| Nantahala Capital Management | 4,610,000 | $5,947,000 | 0.18% |
| Alambic Investment Management, L.P. | 219,090 | $283,000 | 0.18% |
| Wealthstar Advisors, LLC | 73,295 | $95,000 | 0.06% |
| ALGERT GLOBAL LLC | 77,845 | $100,000 | 0.04% |
| Western Standard LLC | 25,935 | $33,000 | 0.02% |
| Allred Capital Management, LLC | 24,995 | $33,000 | 0.02% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 320,993 | $414,000 | 0.02% |